Open-label, multicenter, single-arm study of FABLOx (metronomic 5-fluorouracil plus nab-paclitaxel, bevacizumab, leucovorin, and oxaliplatin) in patients with metastatic pancreatic cancer: Phase I results

V. Sahai, W. Saif, A. Kalyan, P. Philip, C. Rocha-Lima, A. Ocean, M. Ondovik, D. Simeone, M. Karnoub, C. Louis, V. Picozzi

Research output: Contribution to journalArticlepeer-review

Original languageEnglish (US)
Pages (from-to)v43
JournalAnnals of oncology : official journal of the European Society for Medical Oncology
StatePublished - Jun 1 2018

ASJC Scopus subject areas

  • Hematology
  • Oncology

Cite this